세계의 장질환 검사 시장 : 시장 규모 조사 - 질환 유형별, 지역별 예측(2022-2032년)

The Global Enteric Disease Testing Market was valued at USD 3.87 billion in 2023 and is anticipated to grow with a healthy growth rate of 3.3% over the forecast period 2024-2032. Enteric diseases, which affect the gastrointestinal tract, are caused by various pathogens such as bacteria, viruses, and parasites. These diseases include Clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), Helicobacter pylori (H. pylori), salmonellosis, shigellosis, norovirus, rotavirus, amebiasis, cryptosporidiosis, and giardiasis. Diagnostic tests for these diseases involve analyzing samples of stool, blood, or other bodily fluids to identify the specific pathogens responsible.

The market for enteric disease testing is witnessing substantial growth driven by the increasing demand for convenience foods, which has led to a higher prevalence of enteric diseases. Busy lifestyles have prompted consumers to shift from traditional food products to packaged and ready-to-eat meals, which often contain additives and preservatives that can lead to contamination. This shift has heightened the need for enteric disease testing, as the risk of contamination in packaged foods and beverages is higher. Despite the positive market drivers, certain challenges hinder market growth. The lack of stringent regulations governing pathogen testing in developing economies poses a significant restraint. The food industry in these regions is fragmented and dominated by small, unorganized players who may not adhere to proper food testing practices. Additionally, the high cost associated with testing food and water, particularly with automated instruments and advanced technologies, presents a barrier to widespread adoption. Also, technological innovations in the enteric disease testing industry are creating lucrative opportunities for market expansion. Advancements in supply chain technologies have revolutionized the business, reducing lead times and overall testing costs. Improved software, network connectivity, and advanced sensors are gaining traction, making testing more efficient and affordable.

Europe dominated the market with the largest revenue share in 2023, driven by its large geriatric population, particularly in Germany. The aging population is more susceptible to enteric diseases due to decreased immunity levels, increasing the demand for rapid diagnostic techniques such as point-of-care diagnostic devices. Key manufacturers like Roche and Bio-Rad are enhancing their operations in Germany, further boosting the market.

Major market players included in this report are:

• Abbott
• BD
• Biomerica
• BIOMERIEUX
• Bio-Rad Laboratories, Inc.
• Cepheid
• Coris BioConcept
• DiaSorin S.p.A.
• Meridian Bioscience
• Quest Diagnostics Incorporated

The detailed segments and sub-segment of the market are explained below:

By Disease Type:

• Bacterial Enteric Disease
• Viral Enteric Disease
• Parasitic Enteric Disease

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Enteric Disease Testing Market Executive Summary

• 1.1. Global Enteric Disease Testing Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Disease Type
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Enteric Disease Testing Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Enteric Disease Testing Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increase in demand for convenience foods
• 3.2. Market Challenges
  • 3.2.1. Lack of proper regulations governing pathogen testing in developing economies
  • 3.2.2. High cost associated with the testing of food and water
• 3.3. Market Opportunities
  • 3.3.1. Technological innovations in the enteric disease testing industry

Chapter 4. Global Enteric Disease Testing Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Enteric Disease Testing Market Size & Forecasts by Disease Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Enteric Disease Testing Market: Disease Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 5.2.1. Bacterial Enteric Disease
  • 5.2.2. Viral Enteric Disease
  • 5.2.3. Parasitic Enteric Disease

Chapter 6. Global Enteric Disease Testing Market Size & Forecasts by Region 2022-2032

• 6.1. North America Enteric Disease Testing Market
  • 6.1.1. U.S. Enteric Disease Testing Market
    • 6.1.1.1. Disease Type breakdown size & forecasts, 2022-2032
  • 6.1.2. Canada Enteric Disease Testing Market
• 6.2. Europe Enteric Disease Testing Market
  • 6.2.1. UK Enteric Disease Testing Market
  • 6.2.2. Germany Enteric Disease Testing Market
  • 6.2.3. France Enteric Disease Testing Market
  • 6.2.4. Spain Enteric Disease Testing Market
  • 6.2.5. Italy Enteric Disease Testing Market
  • 6.2.6. Rest of Europe Enteric Disease Testing Market
• 6.3. Asia-Pacific Enteric Disease Testing Market
  • 6.3.1. China Enteric Disease Testing Market
  • 6.3.2. India Enteric Disease Testing Market
  • 6.3.3. Japan Enteric Disease Testing Market
  • 6.3.4. Australia Enteric Disease Testing Market
  • 6.3.5. South Korea Enteric Disease Testing Market
  • 6.3.6. Rest of Asia Pacific Enteric Disease Testing Market
• 6.4. Latin America Enteric Disease Testing Market
  • 6.4.1. Brazil Enteric Disease Testing Market
  • 6.4.2. Mexico Enteric Disease Testing Market
  • 6.4.3. Rest of Latin America Enteric Disease Testing Market
• 6.5. Middle East & Africa Enteric Disease Testing Market
  • 6.5.1. Saudi Arabia Enteric Disease Testing Market
  • 6.5.2. South Africa Enteric Disease Testing Market
  • 6.5.3. Rest of Middle East & Africa Enteric Disease Testing Market

Chapter 7. Competitive Intelligence

• 7.1. Key Company SWOT Analysis
• 7.2. Top Market Strategies
• 7.3. Company Profiles
  • 7.3.1. Abbott
    • 7.3.1.1. Key Information
    • 7.3.1.2. Overview
    • 7.3.1.3. Financial (Subject to Data Availability)
    • 7.3.1.4. Product Summary
    • 7.3.1.5. Market Strategies
  • 7.3.2. BD
  • 7.3.3. Biomerica
  • 7.3.4. BIOMERIEUX
  • 7.3.5. Bio-Rad Laboratories, Inc.
  • 7.3.6. Cepheid
  • 7.3.7. Coris BioConcept
  • 7.3.8. DiaSorin S.p.A.
  • 7.3.9. Meridian Bioscience
  • 7.3.10. Quest Diagnostics Incorporated

Chapter 8. Research Process

• 8.1. Research Process
  • 8.1.1. Data Mining
  • 8.1.2. Analysis
  • 8.1.3. Market Estimation
  • 8.1.4. Validation
  • 8.1.5. Publishing
• 8.2. Research Attributes